PRESSURE BIOSCIENCES INC Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Pressure Biosciences Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q1 2024.
  • Pressure Biosciences Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$6.59M, a 105% decline year-over-year.
  • Pressure Biosciences Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$23.2M, a 106% decline year-over-year.
  • Pressure Biosciences Inc annual Nonoperating Income (Expense) for 2023 was -$19.8M, a 77.2% decline from 2022.
  • Pressure Biosciences Inc annual Nonoperating Income (Expense) for 2022 was -$11.2M, a 30% increase from 2021.
  • Pressure Biosciences Inc annual Nonoperating Income (Expense) for 2021 was -$16M, a 39.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$23.2M -$6.59M -$3.37M -105% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-06
Q4 2023 -$19.8M -$6.41M -$3.5M -120% Oct 1, 2023 Dec 31, 2023 10-K 2024-06-07
Q3 2023 -$16.3M -$4.34M -$1.24M -40% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$15.1M -$5.84M -$3.83M -190% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$11.2M -$3.22M -$66.7K -2.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-06
Q4 2022 -$11.2M -$2.91M -$253K -9.52% Oct 1, 2022 Dec 31, 2022 10-K 2024-06-07
Q3 2022 -$10.9M -$3.1M +$610K +16.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$11.5M -$2.01M +$2.08M +50.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$13.6M -$3.15M +$2.35M +42.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$16M -$2.66M +$504K +15.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-12
Q3 2021 -$16.5M -$3.71M -$1.25M -50.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$15.2M -$4.1M -$861K -26.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$14.4M -$5.5M -$2.94M -115% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-19
Q4 2020 -$11.4M -$3.16M -$1.42M -81.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-05
Q3 2020 -$10M -$2.46M -$155K -6.72% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-17
Q2 2020 -$9.84M -$3.24M -$1.87M -137% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-18
Q1 2020 -$7.97M -$2.56M -$1.9M -289% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$6.07M -$1.74M +$120K +6.46% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$6.19M -$2.31M -$1.43M -163% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$4.76M -$1.37M -$6.08K -0.45% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$4.76M -$658K +$465K +41.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 -$5.22M -$1.86M +$2.36M +55.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$7.58M -$875K +$343K +28.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-13
Q2 2018 -$7.93M -$1.36M -$1.98M -319% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 -$5.94M -$1.12M +$124K +9.93% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.07M -$4.22M -$8.63M -196% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 $2.56M -$1.22M -$725K -147% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $3.28M $621K -$1.4M -69.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $4.69M -$1.25M +$3.66M +74.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $1.03M $4.4M +$6.79M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$5.76M -$493K -$526K -1604% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$5.24M $2.02M +$2.34M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$7.58M -$4.9M -$3.73M -318% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-16
Q4 2015 -$3.85M -$2.39M -$2.01M -530% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$1.84M $32.8K +$194K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$2.04M -$322K -$566K -232% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$1.47M -$1.17M -$195K -20% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$1.27M -$379K +$287K +43.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-05
Q3 2014 -$1.56M -$161K -$332K -194% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.23M $244K +$452K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$1.68M -$977K -$923K -1698% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$757K -$666K -$712K -1542% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$45.4K $171K +$280K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$326K -$208K -$381K -220% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $55.4K -$54.3K +$44K +44.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $11.4K $46.2K +$20.8K +81.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$9.36K -$110K -$294K -159% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $284K $173K +$89K +106% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 $195K -$98.3K -$98.6K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 $294K $25.4K Oct 1, 2011 Dec 31, 2011 10-K 2013-05-13
Q3 2011 $184K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $84.1K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-10
Q1 2011 $254* Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.